NCT06436222View on ClinicalTrials.gov

Effectiveness of HVNI in Preterm Infants With Moderate Respiratory Distress

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Respiratory Distress, Newborn
Interventions
DEVICE

HVNI

Preterm infants with gestational age (GA) less than 32 weeks or birth weight less than 1500 grams. The infant has moderate respiratory distress (Downe score ≤ 6) detected within 24 hours after birth.

All Listed Sponsors
lead

Indonesia University

OTHER

NCT06436222 - Effectiveness of HVNI in Preterm Infants With Moderate Respiratory Distress | Biotech Hunter | Biotech Hunter